Results you can see
The EUCRISA clinical trial program included more than 1500 people with mild-to-moderate eczema, ages
MORE PEOPLE SAW CLEAR TO ALMOST CLEAR SKIN AFTER TREATING WITH EUCRISA
Click on the images to see how EUCRISA worked over time to treat eczema.
Photos of a patient treated with EUCRISA in a clinical trial.
STICK WITH YOUR TREATMENT PLAN
Some people using EUCRISA saw results in as little as 8 days, while more people saw clearing by day 29. You should continue to use EUCRISA as prescribed by your doctor.
Some patients may experience burning and stinging where EUCRISA is applied. In our clinical trials, 4% experienced this side effect, and application site pain resolved within 1 day for 78% of patients.
Some people using EUCRISA saw results in as little as 8 days, while more people saw clearing by day 29. You should continue to use EUCRISA as prescribed by your doctor.
Some patients may experience burning and stinging where EUCRISA is applied. In our clinical trials, 4% experienced this side effect, and application site pain resolved within 1 day for 78% of patients.
WHAT IS THE MOST IMPORTANT SAFETY INFORMATION I SHOULD KNOW ABOUT EUCRISA?
EUCRISA may cause side effects including allergic reactions at or near the application site. These can be serious and may include hives, itching, swelling, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away.
In clinical trials, 4% of EUCRISA patients experienced application site pain, such as burning or stinging, vs 1% of those who used the non-medicated vehicle. A long-term safety trial (48 weeks) showed a 2% incidence of application site pain in those treated with EUCRISA.
